Array BioPharma To Present At The Oppenheimer Annual Healthcare Conference
BOULDER, Colo., Dec. 1, 2015 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Ron Squarer, will present at the Oppenheimer Annual Healthcare Conference in New York. The public is welcome to participate in the conference through a webcast on the Array BioPharma website.
Oppenheimer Annual Healthcare Conference
Ron Squarer, Chief Executive Officer
Wednesday, December 9, 2015
10:20 a.m. Eastern Time
About Array BioPharma
Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. Six registration studies are currently advancing related to three cancer drugs. These programs include binimetinib (MEK162), encorafenib (LGX818) and selumetinib (AstraZeneca). For more information on Array, please go to www.arraybiopharma.com.
Array BioPharma Inc.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/array-biopharma-to-present-at-the-oppenheimer-annual-healthcare-conference-300186263.html
SOURCE Array BioPharma Inc.